Deva Holding AS | DEVA - Cost Of Sales


Deva Holding AS reported TRY991.13M in Cost of Sales for its fiscal quarter ending in September of 2023.





Cost Of Sales Change Date
Akebia Therapeutics USD 10.34M 441K Dec/2025
Alaunos Therapeutics USD 0 18K Sep/2024
Avita Medical AUD 3.3M 166K Dec/2025
Deva Holding AS TRY 991.13M 182.81M Sep/2023
Ionis Pharmaceuticals USD 2.74M 261K Jun/2026
IQVIA Holdings USD 3.22B 141M Jun/2026
Moderna USD 93M 862M Jun/2026
Organon & Co USD 711M 34M Jun/2026
Revvity USD 312.82M 10.64M Jun/2026
Viatris USD 2.3B 59.5M Jun/2026
Xeris Pharmaceuticals USD 10.57M 3.08M Mar/2026